In the BioHarmony Drug Report Database

"Preview" Icon

Guselkumab

Tremfya (guselkumab) is an antibody pharmaceutical. Guselkumab was first approved as Tremfya on 2017-07-13. It is used to treat psoriasis in the USA. It has been approved in Europe to treat psoriasis.

 

Trade Name

 

Tremfya
 

Common Name

 

guselkumab
 

ChEMBL ID

 

CHEMBL2364648
 

Indication

 

psoriasis
 

Drug Class

 

Monoclonal antibodies: fully human, interleukins as target

Image (chem structure or protein)

Guselkumab structure rendering